Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

Yazar: Comella, P, Frasci, G, Carnicelli, P, Massidda, B, Buzzi, F, Filippelli, G, Maiorino, L, Guida, M, Panza, N, Mancarella, S, Cioffi, R
Baskı/Yayın Bilgisi 2004

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II st...

Yazar: Frasci, G, Nicolella, G, Comella, P, Carreca, I, DeCataldis, G, Muci, D, Brunetti, C, Natale, M, Piantedosi, F, Russo, A, Palmeri, S, Comella, G, Panza, N
Baskı/Yayın Bilgisi 2001

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.

Yazar: Comella, P., Frasci, G., De Cataldis, G., Panza, N., Cioffi, R., Curcio, C., Belli, M., Bianco, A., Ianniello, G., Maiorino, L., Della Vittoria, M., Perchard, J., Comella, G.
Baskı/Yayın Bilgisi 1996